Premier Research

Janssen Pharmaceutical, Premier collaborate on atrial fibrillation study

Wednesday, April 5, 2017

Janssen Pharmaceuticals is collaborating with Premier on the first and largest study of its kind to address an unmet medical need for hospitalized patients with atrial fibrillation (AF) who are at risk for ischemic stroke. Named QUANTUM AF (Quantify Use of ANTicoagUlation to improve Management of AF), the study will evaluate the effect of a structured hospital quality improvement (QI) program on oral anticoagulant (OAC) use in these patients.

[Read More]

Premier Research receives Metalmark Capital growth investment

Tuesday, October 18, 2016

Premier Research, a middle-market CRO that provides comprehensive clinical development, analytic and support services to pharmaceutical, biotech and medical device customers worldwide, will receive a growth investment from Metalmark Capital, a New York-based private equity firm, which acquired its position from Indigo Capital, a long-established, independently-owned investment firm based in London.

[Read More]

DCRI, Pfizer, Premier partner on vaccination rates

Tuesday, August 30, 2016

A new quality improvement initiative that aims to create effective solutions in optimizing adult vaccination rates has been announced. The program, the Adult Immunization Project, is a collaboration among the Duke Clinical Research Institute (DCRI), Duke Primary Care, Pfizer and Premier. Researchers will jointly work to develop evidence-based interventions to support indicated adult vaccination practices among providers in the Duke Health system.

[Read More]

CROMSOURCE opens North Carolina office, hires four

Monday, May 2, 2016

CROMSOURCE, an international CRO providing a comprehensive portfolio of services to the pharmaceutical, biotechnology and medical device industries, has appointed four senior executives to its management team. The appointments include Dr. Troy W. McCall as chief operating officer (COO), Debbie Kent as global head of TalentSource staffing solutions, Dr. Kerry Dyson as global head of Clinical Research Division and April McCall as vice president of Commercial Operations. Additionally, CROMSOURCE announced the expansion of its North American presence with the opening of an office in Research Triangle Park in North Carolina.

[Read More]